Join ISPOR  | Sign up for mailing List  | Follow Us: LinkedIn Twitter Facebook YouTube

The Official Journal Of The International Society For Pharmacoeconomics And Outcomes Research

» Value in Health Online Access Elsevier Site - MEMBERS
» Value in Health Online Access Elsevier Site - NON-MEMBERS

Value in Health Supplement

Value in Health Supplement

Personalized Medicine and Role of Health Economics and Outcomes Research: Applications, Emerging Trends, and Future Research

Value in Health
iPad® & iPhone® App

Value in Health Smartphone App
Value in Health
Services for Authors
Value in Health Smartphone App
Value in Health Smartphone App
2014 Impact Factor: 3.279 (13% increase from 2013!)

5–Year Impact Factor: 3.373
© 2014 Journal Citation Report®, Thomson Reuters
Ranking 13th out of 89 in Health Care Sciences & Services
Ranking 14th out of 333 in Economics (Social Sciences)
Ranking 7th out of 71 in Health Policy & Services (Social Sciences)

Featured Articles


Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force
This initial task force report presents an overview of the principal methods of MCDA and provides examples of its use in different kinds of decision making in health care.


Thirty Years of Media Coverage on High Drug Prices in the United States—A Never-Ending Story or a Time for Change?
The introduction of a number of breakthrough, highly effective, and high-cost specialty medicines has stoked the fire of the long-burning debate over drug prices.

Issue Highlights


The Cost of Increasing Physical Activity and Maintaining Weight for Midlife Sedentary African American Women
In this article, Tricia Johnson et al. evaluate the marginal costs of increasing physical activity and maintaining weight for a lifestyle physical activity program targeting sedentary African American women.


Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study
Alison Hayes et al. use patient-reported outcomes to measure the impact of complications on summary measures of health-related quality-of-life among people with type 2 diabetes.


An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies
In this study, Koonal Kirit et al. assess differences in time-trade-off valuations using two different comparators (full health and 11111).


The “Efficacy-Effectiveness Gap:” Historical Background and Current Conceptualization
The objectives of this study by Clementine Nordon et al. were to understand the historical background in which the concept of the Efficacy-Effectiveness Gap (EEG) has emerged and to describe the conceptualization of EEG.


The Parity Paradigm: Can Legislation Help Reduce the Cost Burden of Oral Anticancer Medications?
In this policy perspective piece, Sheetal Kircher et al. discuss the history, opportunities, and limitations of drug parity laws in oncology.


The Reporting of Treatment Nonadherence and Its Associated Impact on Economic Evaluations Conducted Alongside Randomized Trials: A Systematic Review
The objectives in this review by Samuel Brilleman et al. were to examine trial-based economic evaluations and to identify: 1) the proportion reporting adherence; 2) the methods for assigning intervention costs according to adherence; 3) participants who were included in the economic analysis; and 4) the statistical methods to estimate cost-effectiveness in those who adhered.


recent Issues

Volume 18 Issue 8 (December 2015)

Volume 18 Issue 8 (December 2015)

Volume 18 Issue 7 (November 2015)

Volume 18 Issue 6 (September/October 2015)

Volume 18 Issue 5 (July/August 2015)
Volume 18 Issue 4 (June 2015)
Volume 18 Issue 3 (May 2015)
Volume 18 Issue 2 (March/April 2015)
Volume 18 Issue 1 (January/February 2015)
Volume 17 Issue 8 (December 2014)

Volume 17 Issue 7 (November 2014)

Articles in Press

ISPOR Article Press Releases

Submit your Manuscript

ISPOR Award for Value in Health Paper of the Year

Lucas Goossens Lucas Goossens is an Assistant Professor of Quantitative Analysis at the institute of Health Policy and Management (iBMG) and the institute for Medical Technology Assessment (iMTA) of Erasmus University Rotterdam in the Netherlands. His research is centered around economic evaluations in healthcare and broader epidemiological studies. He has published in health economic, medical, and epidemiological journals on topics such as interventions in pulmonary diseases, patient preferences, hospital-at-home schemes, and medication adherence.
View Award Information »
Value in Health Twitter
Latest Tweet
Value in Health Co-Editors-in-Chief
Michael Drummond, DPhil and C. Daniel Mullins, PhD discuss their goals for the journal's future


Full-text articles are available from 1998 (Volume 1, Issue 1) to the present for ISPOR members. All article abstracts are freely available to all visitors and all content is freely available to all visitors 12 months after publication. Online access to the full text of the current issues of Value in Health is a benefit of ISPOR membership.

ISPOR members can access Value in Health content by logging in here. If you have accessed the Value in Health issue page via the ISPOR website, you do not need to log in again.

If you wish to personalize your experience on the Value in Health page (e.g., save searches, view recent searches, receive email alerts), you will need to create an account at the Value in Health page or log in if you have already created an account. [See Login/Register in upper right hand corner]. It is suggested to use your ISPOR user name (your email address) and your ISPOR password (ISPOR member ID number) as a 5 character password. [For example, if your member ID number is 500, use 00500 as your password]

If you have already registered and successfully claimed access to Value in Health, please log in at Login at the upper right corner of the Value in Health page using your current account information (i.e. the "username" and "password" you selected upon registering here). You will then be able access current Value in Health content.

Contact ISPOR @  |  View Legal Disclaimer
©2016 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.